Buy or sell guide
Should I Buy UNH Stock Right Now?
A fast read on Wall Street conviction, live analyst commentary on X, and current valuation context for UnitedHealth Group Incorporated.
Updated 2026-06-20
Wall Street currently rates UNH buy with a 12-month price target of $426 (+6.2% upside). The sections below cover the bull case, key risks, and latest earnings context for UNH.
Wall Street
Buy52 analystsConsensus target
$426 target (+6.2%)Current price $400.96Analyst sentiment
No recent analyst posts capturedWaiting for fresh postsEarnings context
EPS beat 9.9%Reported Tue Apr 21Wall Street verdict
Should I Buy UNH Stock? Here's What Analysts Think
52 analysts currently cover UNH. Below is their consensus rating, price target range, and implied upside.
According to 52 analysts, UnitedHealth Group Incorporated (UNH) is rated Buy with a consensus 12-month price target of $426 — representing 6% upside from today's price of $401. The bull case target is $492, the bear case is $361.
UNHBuy
From 52 analyst ratings- Current price
- $400.96
- Consensus Target
- $426 (+6.2% upside)
- Forward P/E
- 21.8x
- Coverage
- 52 analyst ratings
High target$492
Low target$361
At $400.96, the consensus setup implies +6.2% versus the 12-month target.
- 43 of 52 analysts lean Buy or Strong Buy, while 5 stay on Hold and 4 lean bearish.
- UNH trades at roughly 21.8x forward earnings, so the bull case still depends on growth staying strong.
- Analysts span a wide range from $361 to $492, so conviction matters as much as the consensus target.
Below, compare that institutional answer with the live analyst commentary on X for UNH right now.
Analyst ratings update weekly. Get UNH's next verdict in your inbox.
Free. No account needed. Unsubscribe any time.
9 of 9 analysts raised targetsMizuho $460JP Morgan $466Morgan Stanley $453+5 more
Jun 2026Live commentary on X
What Analysts Are Saying About UnitedHealth Group Incorporated Right Now
Real posts from high-reach stock analysts mentioning UNH, shown exactly as written. Sorted by engagement — most discussed first.
No recent posts captured
No high-reach analysts have posted about UNH in the last 7 days. Check back after the next earnings release or market-moving event.
Should you buy UNH?
Is UNH a Buy, Hold, or Sell Right Now?
A structured look at the bull case, the risks, and the most recent earnings execution for UNH before you decide whether to buy, hold, or sell.
Current setup
UNH beat estimates last quarter. Below are the key reasons analysts remain constructive and the risks that could change that view.
Bull Case
What keeps the long thesis intact
- Improved Medical Care RatioQ1 2026 MCR improved to 83.9%, down from 84.8% in Q1 2025, indicating better management of medical costs.
- Raised EPS GuidanceUnitedHealth raised its full-year 2026 EPS guidance to over $18.25, reflecting management's confidence.
- Strong Q1 2026 EarningsQ1 2026 EPS was $7.23, exceeding expectations by 10%, with revenue at $111.7 billion.
- Attractive ValuationThe stock trades at a forward P/E ratio of 13x-19x, the cheapest in over a decade, attracting value investors.
- Operational Discipline FocusShift towards operational discipline and margin improvement signals long-term stability.
- Positive Analyst SentimentConsensus rating of 'Moderate Buy' with a majority recommending 'Buy' or 'Strong Buy'.
Wall Street rates UNH buy, giving the bull case institutional backing from 52 analysts.
Watch Out For
What can break the setup quickly
- DOJ InvestigationsOngoing investigations by the DOJ into Medicare Advantage billing practices pose significant risks.
- Membership Losses ExpectedUNH anticipates losing over 3 million members in 2026, leading to the first revenue decline in a decade.
- Rising Margin PressureAdjusted medical care ratio rose to 88.9% in FY2025, indicating rising utilization trends and funding cuts.
- Leadership TurbulenceSignificant leadership changes, including a CEO murder and resignation, could impact stability.
- Value Trap RisksDespite low valuation, ongoing investigations and operational challenges may limit upside potential.
- Negative Analyst RatingsSome analysts have issued 'Sell' ratings due to concerns about valuation and growth.
Watch whether new negative commentary on UNH points to these structural risks or is simply reacting to short-term price moves.
UNH Earnings Reaction — What the Last Quarter Showed
Last Quarter
- EPS
- $7.23 vs $6.58 est.Beat 9.9%
- Revenue
- $111.7B vs $109.4B est.Beat 2.1%
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into UNH consensus models and risk factors.
View Analysis
Should I Buy UNH?
Wall Street verdict, signals, and target summaries.
See Verdict
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
UNH — Frequently Asked Questions
Quick answers to the most common questions about buying UNH stock.
Should I buy UNH stock right now?
Verdict
UNH appears fairly valued near today's $400.96 — the consensus rating is "Buy" with a $426 target (+6.2%). This is informational only — verify the data and consider your own risk tolerance before deciding.
Is now a good time to buy UNH?
Timing
Timing depends on your horizon, but the data signals are: consensus rating "Buy" with +6.2% upside to the $426 target. In the past 30 days, 9 of 9 covering analysts raised their price targets — a bullish signal.
What is the price target for UNH stock?
Price Target
UNH's consensus 12-month price target is $426, set by 52 Wall Street analysts. The bull case high is $492 and the bear case low is $361. From the current price of $400.96, this implies +6.2% upside.
Is UNH overvalued or undervalued?
Valuation
UNH appears fairly valued — the $426 consensus target is roughly in line with today's $400.96 (+6.2%). It trades at a forward P/E of 21.8x. Targets range from $361 (bear) to $492 (bull), reflecting different assumptions about growth and margins.
Should I buy UNH before earnings?
Earnings
UNH reports next quarter. Earnings-week moves are volatile — historically, analyst targets revise upward after a beat and downward after a miss. The current consensus is "Buy" with a $426 target. Consider position sizing rather than going all-in pre-print.
What are analysts saying about UNH stock?
Coverage
Of 52 analysts covering UnitedHealth Group Incorporated (UNH): 0 Strong Buy, 43 Buy, 5 Hold, 4 Sell, 0 Strong Sell — a "Buy" consensus. The 12-month price target is $426 (range $361–$492). Bullish analysts outnumber bearish by more than 2-to-1.
What are the risks of buying UNH stock?
Risks
4 of the 52 analysts covering UNH rate it Sell or Strong Sell. Common concerns include valuation stretch, slowing growth, and sector-specific headwinds — see the Bull vs. Risk cards above for the specific theses on UnitedHealth Group Incorporated.
This page is for informational purposes only and does not constitute financial advice. Always conduct your own research before investing.